Cancer is one of the leading causes of morbidity and mortality worldwide. Significant
improvements in the modern era of anticancer therapeutic strategies have increased the …

As a result of ongoing breakthroughs in cancer therapy, cancer patients' survival rates have
grown considerably. However, cardiotoxicity has emerged as the most dangerous toxic side …

Cancer is the leading cause of morbidity and mortality in the United States and globally.
Owing to improved early diagnosis and advances in oncological therapeutic options, the …

Anthracyclines, such as doxorubicin (DOX), are well known for their high efficacy in treating
multiple cancers, but their clinical usage is limited due to their potential to induce fatal …

Cancer treatment has made significant progress in the cure of different types of tumors.
Nevertheless, its clinical use is limited by unwanted cardiotoxicity. Aside from the …

Considerable progress has been made in managing cancer; however, with these
advancements comes the discovery of previously unknown adverse events. In particular, the …

Molecular mechanisms underlying heart failure (HF) are only partly understood. Non‐coding
RNAs (ncRNAs) have been reported to control function and signalling routes in the …

An increasing body of research suggests cancer-induced cardiovascular diseases, leading
to the appearance of an interdisciplinary study known as onco-cardiology. Lung cancer has …

Abnormally expressed long noncoding RNAs (lncRNAs) has been recognized as one of the
key source in cardiac diseases. However, the role of lncRNA in doxorubicin (DOX)-induced …

Cardiotoxicity associated with breast cancer treatment is an important concern in the
oncology clinic. Different types of anti-cancer therapies have recorded high rates of cardiac …